Our monitor has extensive experience in monitoring phase I to IV studies in a range of therapeutic areas including: cardiology, oncology, neurology, endocrinology, immunology, infectious diseases, rheumatology and nephrology.
We can start up your project and carry out site feasibility assessments, regulatory and ethics submissions and site initiation visits. We’re very familiar with Hong Kong Department of Health and Hong Kong Hospital Cluster requirements and regulations and can put your submission pack together for you.
We can conduct regular site monitoring, carry out source data verification and ensure adherence to GCP. We can check a site’s facilities, equipment, drug supply, study site files and make sure they’re providing good quality data. We’re also happy to provide remote site monitoring. At the end of the study, we can help you close-out and archive. We’ve prepared for audits! So we know how to help you do the same and ensure everything is in order.
We’re firm believers in keeping good, strong relationships with site staff and we’ll work hard to maintain these relationships and provide you with comprehensive reports on site progress and recruitment.
Most importantly, we can make sure your patients are safe throughout the course of the study.
Contact us today and have a chat with our friendly CRA.